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The cardiotoxidty of streptolysin O was first demonstrated by Bemheimer 
and Cantoni (1)  who induced systolic contracture in the frog heart perfused 
with the toxin. Subsequently,  Kellner et al. (2)  showed that permanent and 
irreversible standstill, accompanied by a profound but transitory reduction in 
coronary flow, resulted from the exposure of the isolated hearts of guinea pigs, 
rabbits, and rats to small amounts of the toxin. Halpem and Rahman (3) found 
that the electrocardiograms  of mice given large lethal doses of toxin exhibited 
immediate and intense bradycardia followed, in  some  cases,  by  temporary 
arrest; progressive atrioventricular dissociation implicated the conductile tissue. 
Electrocardiograms,  obtained by Halbert, Bircher, and Dahle (4) from rabbits 
given lethal and sublethal doses of highly purified streptolysin O, were char- 
acterized  by conduction defects and ventricular automatism. Intravenous in- 
jection of several multiples of the Ires0 was followed within 3-4 sec by a rapid 
transition from normal sinus  rhythm to ventricular arrhythmia, ventricular 
fibrillation, and standstill. Frequently, smaller lethal doses and sublethal doses 
immediately produced a pronounced but transient sinus bradycardia, followed 
by temporary or permanent recovery. The transient nature of this bradycardia, 
along with the extremely rapid effects of the toxin in vivo, suggested that its 
toxicity might result from the release of vasoactive substances rather than from 
the direct action of the protein itself. Accordingly, Halbert et al. (5) studied the 
effectiveness of various pharmacological blocking agents in protecting against 
the putative physiologically  active agent(s)  responsible  for the intravenous 
effects of streptolysin O. Although the several agents which exhibited protection 
were serotonin  antagonists, there was little correlation  between this property 
and protection.  In addition, serotonin was not very toxic to rabbits and mice, 
so it appeared  unlikely that the acute toxicity of streptolysin O could be ac- 
counted for entirely by the release of this amine. 
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and by Contract No. ONR 225(46) between Stanford University  and The Office of Naval 
Research, and Public Health Service 1 T1 A1 306. 
~; On leave from the Laboratory  of Technical Development, National Heart Institute, 
National Institutes  of Health, Bethesda, Md. 
1401 1402  ACTION OF STREPTOLYSIN O  ON CARDIAC TISSUE 
In subsequent studies, Halbert et al. (6)  considered the likelihood that  the 
in vivo cardiovascular changes observed were consequent to an elevated plasma 
potassium  concentration  resulting from  intravascular hemolysis. They found 
sufficient discrepancies, however, in the relationships among hemolysis, potas- 
sium levels, and electrocardiographic changes to render inadequate this mecha- 
nism as being responsible for the rapid lethality of the toxin. Furthermore, the 
pharmacologic agent most protective against this lethality had no effect against 
hemolysis or the toxicity of KC1. 
The present work (see also reference 7) endeavors to extend the in vitro stud- 
ies (1, 2)  and to investigate the provocative in vivo electrocardiographic find- 
ings  (3-6)  by  an  analysis  of  the  electrophysiological, pharmacological,  and 
mechanical changes occurring in the isolated whole heart and separate cardiac 
tissues of the guinea pig pursuant to their challenge with streptolysin O. 
Materials and Methods 
Toxin.--Highly purified preparations of streptolysin O, obtained from Group A and Group 
C streptococcal extracellular  concentrates, were supplied as lyoph~l~zed  powders in the oxidized 
state.  ~ These preparations were made according to methods previously described  (8-12)  and 
had been used in other studies (4-6). The Group A toxin consisted entirely of protein and had 
a titer of 160,000 hemolytic units (HU) per milligram of dry weight; the Group C material, 
which was 67% protein, had a tlter of 40,000 HU/mg. 
In experiments on guinea pig cardiac tissues, the Group A and Group C preparations be- 
haved identically, producing  comparable physiological  effects when  present  in  the  same 
hemolytic potencies. In both cases, the magnitudes of these effects correlated closely with  the 
hemolytic  activities. 
Toxin stock solutions were prepared daily by dissolving the lyophilized powder in 0.15 ~* 
sodium phosphate buffer of pH 7.3. The toxin was activated by reduction with 10 mg/ml 
L-cysteine-HCl. The reduction reaction was allowed to proceed for 10 min at 30°C, after which 
the activated stock solution was placed in an ice bath. The direct effect of cysteine on the 
whole heart and isolated atria, a slight depression of rate and amplitude, was largely  eliminated 
by diluting the stock toxin solutions at least 1 : 10 with buffer before testing them on the tissue. 
Antiloxin.--Normal pooled human gamma globulin  (E. R. Squibb & Sons, New York), 
a 16% solution containing known streptococcal antibodies with an anti-streptolysin O titer 
of 2000 Todd anti-streptolysin units/ml (8-11),  was furnished  through  the American Red 
Cross. Two purified plasma proteins, human serum albumin (Cutter Laboratories, Berkeley, 
Calif.), and bovine gamma globulin  (Armour  & Co., Chicago, Ill.), were used for control of 
antitoxin. 
Organi¢ Reagents.--The  cholesterol 2  used to inhibit streptolysin  O activity  was recrystallized 
four times from ethanol and prepared as an aqueous suspension according to the method of 
Cohen et al. (13). Various pharmacological agents, prepared in 1% NaC], were used in several 
phases of the analysis of the mode of action of the toxin. These included: (a) acetylcholine 
chloride; 8 (b) atropine sulfate;* (c) eserine salicylate;  2 (d) Na-heparin;  * (e) 1-methyl-d-lysergic 
x  The authors are indebted to Dr. S. P. Halbert of the Department of Pediatrics, School of 
Medicine, University of Miami, Fla., for these preparations. 
• Obtained from Nutritional Biochemical  Corp.,  Cleveland,  Ohio. 
3 Obtained from Merck and Co., Inc., Rahway, N. J. B.  A.  REITZ~ D.  J.  PRAGER~ AND  G.  A.  FEIGEN  1403 
add butanolamide bimaleate (UML-491);  4 (f) serotonin creatinine sulfate;  ~ and  (g) n-acetyl 
serotonin. ~ 
N~dri~nt Media for Isolated Tissues.--Studies  involving the  isolated  cardiac  tissues  of 
guinea pigs, rabbits, and rats were carried out in Chenoweth's solution (14); the bioassays on 
the guinea pig ileum, in Tyrode's solution. Both media were prepared daily from reagents of 
analytical grade in water redistUled  over alkaline permanganate.  Chenoweth's solution was 
continuously equilibrated with 95% O~-5% CO2 to give a pH of 7.4; Tyrode's solution, pH 
7.8, was gassed with 100% O~. 
Experimental Anima/s.--Normal  male guinea  pigs,  ranging  in  weight  from  250-500  g, 
were used in these studies. 
Preparation of Tissue.--Cardiac  tissues were prepared  according  to  a  common general 
procedure (15-17).  Each animal was primed with an intraperitoneal dose (5 mg/kg) of sodium 
heparin and killed 10 min later by a blow to the base of the skull. After cannulation of the 
ascending aorta, the heart was excised,  connected to the standpipe of an Anderson perfusiou 
apparatus,6  and perfused at 37°C.  Such hearts were either left in place or removed and ap- 
propriately dissected for experiments on the separate cardiac tissues. 
In studies of the mechanical and electrical responses  of isolated atrial pairs, the atria were 
dissected as a single tissue from the ventricles. Individual left or right atria were prepared 
from atrial pairs surgically separated so that the sinoatrial node remained intact in the tight 
atrium. Isolated ventricle strips were obtained from hearts treated  as described above and 
prepared as described by Feigen et al. (18). 
Procedurea ar~t Apparatus.--Intact  whole hearts were perfused through the coronaries on 
the Anderson  apparatus.  The perfusion rate was  measured by collecting the perfusate in 
graduated  tubes at 30  see intervals. Contractions were recorded on an Offner Dynograph, 
Type 506, by means of a transducer attached through a thread to the apex of the ventricles. 
Toxin and pharmacological agents were added to the standpipe above the heart and flushed 
through the tissue with normal Chenoweth's; atropine or eserine,  dissolved in  Chenoweth's, 
was continuously perfused through the heart. 
Simultaneous recordings of the electrophysiological and mechanical activity of atrial and 
ventricular tissues were made using equipment and  methods adequately described previously 
(15,  16). Intracellular potentials,  measured  with standard  glass  microelectrodes,  and  me- 
chanical activity, monitored by a moveable-anode transducer,  were displayed on a twin beam 
oscilloscope and photographed by an oscilloscope camera.  Atrial preparations were stimulated 
with a biphasic 1.0 msec pulse, 10 v above threshold, at  a rate approximately 10 beats/rain 
above the natural rate. Ventricle strips were similarly driven at a rate of 180 beats/min. 
The mechanical activity of isolated, spontaneously beating atria  was studied on tissues 
mounted vertically in water-jacketed muscle baths having a volume of 3.5 ml. The recording 
system consisted of a Statham G-TA transducer, G-18 control box, and the Offner Dynograph. 
Temperature was maintained at 30 4- 0.5°C; at this temperature the rate was 53%, of that 
at 37°C, and the contraction amplitude 210% of that  at 37°C; preparations  were stable for 
at least 20 hr. 
The bioassays for acetylcholine were made on strips of guinea pig's ileum prepared  and 
standardized  according to the usual techniques employed in this laboratory  (19,  20).  Each 
strip was secured to a glass rod and mounted in a 3.5 ml, water-jacketed muscle bath main- 
talned at 37°C. 
4 Obtained from Sandoz Pharmaceuticals, Hanover, N. J. 
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RESULTS 
The Action of Stmptolysin 0 on the Whole Heart.--The addition of a small dose 
(36 HU) of active toxin to the solution perfusing an isolated guinea  pig heart 
resulted in a gradual, monotonic decrease in the amplitude of contraction (Fig. 
1 A). As the dose of streptolysin O was increased, the character of this response 
was altered by the appearance of a rapid, but transient, decrease in the rate and 
amplitude, superimposed  on the gradual decline (Fig. 1 B-1 D). Larger doses 
produced  an immediate, reversible cardiac arrest (characterized  by both atrial 
and ventricular standstill)  followed by partial recovery of the rate and ampli- 
FIc. 1.  The responses  of four isolated hearts recorded st various times following challenge 
with different doses of the Group A toxin (37°C). 
tude before the long-term  effect became  dominant (Fig.  1 D). This biphasic 
nature of the response is illustrated graphically in Fig. 2, which describes the 
responses of three hearts to different doses of toxin. 
These mechanical  changes were accompanied  by marked alterations in the 
rate of cardiac  perfusion  (2). Doses of streptolysin O greater than about 120 
units produced an immediate and permanent cessation of flow. Hearts subjected 
to such levels of toxin always stopped beating completely within 6-15 rain after 
challenge. In these cases, it was not possible to separate  the consequences of the 
direct action of the toxin  on  the contraction processes, from the deleterious 
effects of the decreased perfusion. These effects are shown by the dashed curve 
of Fig. 2,  which  represents  the decrease  in amplitude subsequent to clamp- B.  A.  REITZ~ D.  J.  PRAGER,  AND  G.  A.  FEIGEN  1405 
ing off the flow of perfusion fluid to a normal heart. The resulting decline in 
force of contraction closely parallels that seen with the higher doses of toxin. 
Lower levels of streptolysin O induced a rapid, but transient, decrease in per- 
fusion rate. In these cases, the flow gradually recovered to an extent inversely 
dependent upon the dose of toxin, and the hearts did not stop beating but con- 
tinued to contract indefinitely at a  small fraction of their control amplitude 
(see Fig. 1 A and B). Although flow sometimes returned to as much as 95 % of 
the control level, the amplitude of contraction never recovered to more than 
about 15 % of its prechallenge level. 
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FIG. 2. The effect of various doses of Group A streptolysin O on the amplitude of con- 
traction of the  isolated heart:  (•  •  36 HU, •  •  264 HU, H  528 HU); 
comparison with the effect of stopping the flow of peffusion  fluid (-  .... ). All at 37  ° C. 
In hearts reacting to large doses of toxin, the depression, or even the complete 
cessation, of activity during the initial phase was common to both atria and 
ventricles. Similarly, the partial spontaneous recovery of rate and amplitude 
was shared by both tissues. At the height of the recovery, however, the ventricles 
began to lose contractile force. They became partially, and then completely, dis- 
sociated from sinoatrial rhythm and began to beat irregularly. The atria, on the 
other  hand,  continued  to  recover  and,  at  ventricular  standstill,  still  beat 
strongly. If such intoxicated hearts were then dissected and the atria and ven- 
tricles separately tested, it was found that the atria would beat  spontaneously 
and  vigorously at  their  control  rates  for many  hours  and  that  electrically 
driven ventricle strips were indistinguishable in their performance from strips 
obtained from normal hearts. 1406  ACTION OF STREPTOL¥SIN O  ON CARDIAC TISSITE 
These preliminary observations suggested that the localization of the physio- 
logical disturbance and the analysis of the mode of action of the toxin might be 
facilitated by first studying the behavior of the individual cardiac tissues rather 
than  the whole organ. 
The Action  of Streptolysin  0  on the  Isolated Atria.-- 
Mechanical properties:  The characteristic response of the spontaneously beat- 
ing  atria to activated streptolysin O  consisted of a  lag period followed by a 
transient decrease in rate and amplitude of contraction (Fig. 3). The lag period, 
the time between administration of the test dose and the onset of the response, 
was inversely dependent upon the toxin concentration. When plotted semilog- 
FIG.  3.  The recorded responses of four preparations of isolated atria to different  concen- 
trations of streptolysin O.  Washing out  the bath with fresh medium  (W)  accelerates the 
recovery (30°C). 
arithmically, the lag period decreased linearly at a  rate of 11  sec per 10-fold 
increase in toxin dose (e.g.: 26 sec at 100 HU/ml, 15 sec at 1000 HU/ml). 
Dose-response functions of the transient changes in atrial rate and amplitude 
were sigmoidal. These functions showed that the toxin exerted a much more pro- 
found depression on the force of contraction than  on  the  frequency:  a  dose 
of 25 HU/ml, which produced a 50% reduction in force, depressed the rate by 
only 3 %. 
The spontaneous recovery of the atria from the depressant effects of the toxin 
was characterized by a transient potentiation in rate and amplitude above con- 
trol values. Washing out the bath after challenge accelerated the recovery and 
exaggerated the potentiation. B.  A.  REITZ,  D.  J.  PRAGER,  AND  O.  A.  ]~EIGEN  1407 
Qualitative tests on rabbit and rat atria showed that these tissues exhibited 
the same characteristic response to the toxin. 
The repeated challenge of guinea pig atria with a  constant dose of  strepto- 
lysin O  produced  a  gradual  decline  in  responsiveness.  This  tachyphylaxis is 
exhibited in the tracings of Fig. 4  taken from an atrial preparation subjected 
four times to challenge with 115 HU/ml. Each successive challenge was char- 
acterized by a  prolongation of the lag peroid and a  reduction in the depth  of 
FIo. 4. Tachyphylaxis to streptolysin 0  in the isolated atria: the effect of four successive 
challenges with the same dose of toxin on the magnitude of response at 30°C. 
TABLE I 
The Effect of Dose on Atrial Tachyphyla:ds to Streptolysin 0 
I 
Toxin concentration (HU/ml)  35  [  115  158  176  350 
Velocity constant, K*  0.190  [  0.322  0.338  0.342  0.436 
* K, the slope of the line relating the logarithm of the per cent depression of contraction 
amplitude with the challenge number. 
response. The rate of decline of responsiveness was dose dependent, and semilogo 
arithmic plots of these functions were linear. The first order velocity constants 
(K), derived from these plots,  are presented in Table I. Table II shows that 
there was no recovery of responsiveness with time. A  single atrial preparation, 
challenged six times with  158 HU/ml of streptolysin O, was then maintained 
for 250 min in frequently renewed  medium before the  seventh challenge.  In 
spite of this considerable delay, the response to the seventh challenge was still 
less than that observed for the sixth challenge. 
Electrical properties: The electrophysiological consequence of exposing driven 
atria to streptolysin O  was to increase the rate of repolarization of the action 1408  ACTION  OF  STR.EPTOLYSIN  0  ON CARDIAC TISSUE 
potential. Fig. 5 presents oscillographic records of the intracellular potential 
and mechanical contraction before (trace A), and 45 sec after (trace B), chal- 
lenge with 140 HU/ml of reduced toxin; quantitatively, treatment of an atrial 
preparation with 720 HU/ml of active toxin for 45 sec increased the initial slope 
of the repolarization phase of the potential from the control rate of 0.73 v/sec 
TABLE  II 
The E~e.ct of Time on Atrial Ta~hyphylaxis  to Streptolysln 0 
Chal]enge No. 
Challenge  with 158 HU/ml 
Time between challenges 
mla 
i0 
I0 
I0 
I0 
I0 
250 
Depression of amplitude 
% 
77.2 
49.9 
31.1 
29.2 
22.6 
22.0 
21.6 
A. CONTROL 
/ 
B. 45sec  after SLO(140 HU/ML) 
I  ! 
20  msec  5.0  msec 
FIG.  5.  Oscillographic recordings of the contraction (upper trace in each frame) and in- 
tracellular action potential of the isolated atria before (A), and 45 sec after (B), challenge with 
streptolysin O  at 37°C. B.  A.  REITZ,  D.  J.  PRAGER,  AND  G.  A.  ]~EIOEN  1409 
to 2.4 v/sec without measurably affecting  the depolarization phase.  In these 
studies, the mechanical and electrical changes began within 20-60 sec following 
the addition of the toxin; but, whereas the action potential returned to its con- 
trol configuration  in 2-3 rain,  the contraction did not fully recover until 8-12 
rain after challenge.  Additional electrophysiological  studies made on separated 
atria showed that there was no difference between the right and left atria  with 
respect to their electrical or mechanical reactions to streptolysin O. 
Evidence  for Release of Acetylchobine by Toxin-Treated Atria.--From a careful 
analysis of electrocardiographic  records (those cited in references 3 and 4)  as 
FIo. 6.  The recorded responses of isolated atria to five concentrations of acetylchollne at 
37°C. The e~ect of w~h~ng out (W) the bath on the rate of recovery. 
well as from the transiently decreased frequency, amplitude of contraction, and 
increased rate of repolarization observed in the present experiments, there was 
sufficient circumstantial evidence to suggest that the reversible phase of strepto- 
lysin cardiotoxicity was due to the release of acetylcholine.  In order to test this 
idea, it had to be shown by quantitative experiments that both acetylcholine 
and  streptolysin O,  given in  comparably effective doses, produced identical 
electrical  and  mechanical  changes;  that  both  effects  could  be  blocked  by 
atropine and potentiated by eserine; and, finally,  that the release of acetylcho- 
line  from  atria  challenged  with  streptolysin  0  could be  demonstrated  un- 
equivocally. 1410  ACTION OF STREPTOLYSIN O  ON CARDIAC TISSUE 
Comparison of the effects of acetylcholine and streptolysin 0 on the isolated atria: 
The responses of isolated atrial preparations to five concentrations of acetyl- 
choline are shown in the recordings of Fig. 6. They consist of a dose-dependent 
decrease in rate and amplitude of contraction followed by spontaneous recovery 
characterized by a transient potentiation. This pattern of response is identical 
with that observed in tissues challenged with streptolysin O (see Fig. 3). How- 
ever, unlike streptolysin O which depressed the amplitude of contraction less 
with each repeated challenge, the reaction to iterated doses of acetylcholine was 
one of slight potentiation. 
Electrophysiologically, the treatment of electrically driven atria with acetyl- 
choline resulted in a dose-dependent increase in the rate of repolarization of the 
intracellular potential as seen in Fig. 7 B. These effects are quite similar to those 
produced by streptolysin O (see Fig. 5). 
Effects of pharmacological agents: If the release of acetylcholine is a significant 
component of the atrial response to the toxin, the reaction to streptolysin O 
ought to be blocked by atropine and potentiated by eserine. The ability of 
atropine to block the electrophysiologicM  manifestations of streptolysin O action 
on the isolated atria is demonstrated in Fig. 7. The presence of atropine, in a 
concentration sufficient to eliminate the striking increase in the rate of repolar- 
izafion produced by 2.5 X  10  -z ~  acetylcholine (Fig. 7 B), completely blocked 
the effects of streptolysin O on the repolarization rate (Fig. 7 D, compare with 
Fig. 5 B). 
The actions of atropine and eserine on the mechanical changes produced by 
streptolysin O are shown in Fig. 8. The slight depression of amplitude caused by 
30 HU/ml of toxin (atria A) turned into a profound and prolonged depression of 
amplitude and frequency when this test dose of toxin was given to an atrial 
preparation surviving in the presence of 6.9 X  10  -7 M eserine (atria B). On the 
other hand, the effects of a trebled concentration of toxin were seen to be blocked 
completely in the presence of 8.2 X  10  -7 ~ atropine (atria C). 
Detection and estimation of acetylckoline released from atria exposed to strepto- 
lysin O: Although circumstantial, the foregoing evidence was entirely consistent 
with  the hypothesis that  the  toxin preparations  released  acetylcholine from 
atrial tissues. However, initial attempts to demonstrate de facto release from 
single, or even multiple (three) atrial preparations by assaying the bath or per- 
fusion fluids were unsuccessful, presumably because of (a) the presence of power- 
ful tissue acetylcholinesterases, and (b) the high degree of dilution to which any 
net release inevitably was subjected. 
A test of the potency of atrial acetylcholinesterases was made by determining 
the rate of inactivation of exogenous acetylcholine. Four atria were assembled 
into a bundle and immersed in 10 ml of gassed Chenoweth's solution containing 
10.8 X  10  -4 #moles of acetylcholine chloride. The reaction was allowed to pro- 
ceed at 37°C for 12 min during which 0.1 ml samples were drawn at the times A. CONTROL 
_J 
B. 50 sec  after ACh(25xlO-TM) 
_JL_ 
C.50 sec after ACh (2.5xlO'TM) 
•  sent(8.  - 
D. ,$5 sec after  SLO(i4OHU/ML) 
esent(8.?_xlO-TM)  - 
20mv  I  20mv  I 
,  !  I 
50  msec  5.0 msec 
FIG. 7.  The contraction and intracellular potential of an isolated atrial preparation before 
(A) and 30 sec after (B) challenge with acetylcholine. Atropine, at a concentration sufficient 
to block this dose (C), completely eliminates the effects of 140 HU/ml of streptolysin O (D; 
compare with Fig. 5 B). 
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indicated  in  the  protocol given  in  Table  III. The  concentrations  of residual 
acetylcholine at these times were obtained by bioassay on the guinea pig's ileum. 
The results given in Table III show a linear reduction in concentration over the 
first 12  mln. When  these data  were corrected for  the dry weight of the  tissue 
Fla. 8. The response of an isolated atrial preparation  to 30 HU/ml of streptolysin O (atria 
A). Modification by eserine of the response of another  atrial  pair challenged simultaneously 
with the same toxin concentration  (atria B), and by atropine of the response of a third prepa- 
ration to a threefold increase in toxin dose (atria  C). A dose of 89 HU/ml of active  toxin 
produced no effect when first incubated  with  cholesterol (atria  D). Heating the toxin  first 
(56°C, l0 rain) also destroyed its depressant effects (atria E). (30°C.) 
(98.5  rag)  the initial  rate  of destruction  at 37°C was found to be  3.4  X  10  -4 
/zmoles acetylcholine/g dry atrium/min. 
From these  results,  it was  clear that  measurable  amounts  of  acetylcholine 
could be obtained only if a large quantity of atrial tissue were challenged in the 
presence of eserine,  and if samples of reaction fluid were taken at a  very early 
stage in the reaction. As further steps,  very high concentrations of toxin were 
used and the reaction temperature was lowered from 37°C to 25°C. 
Accordingly,  10 pairs  of atria  were  assembled  into  a  bundle  and immersed B.  A.  REITZ,  D.  J.  PRAGER,  AND  G.  A.  ~EIGEN  1413 
into a 6.0 X  10  -v ~  solution of eserine made up in Chenoweth's medium. After 
an equilibration period of 3 min the tissue was transfrered to a flask containing 
streptolysin O  (838 HU/ml) in eserinized Chenoweth's. At the same time, for 
control purposes, an appropriate quantity of toxin was added to the original 
equilibration flask to bring the toxin concentration to the same strength as that 
present in the challenge solution. After 3 min of reaction, the tissue was removed 
and its dry weight determined. The solutions from both flasks were transferred 
into 15 ml centrifuge cones, heated to 56°C for 10 rain to inactivate the toxin, 
chilled, centrifuged at 5°C for 15 min, and then bioassayed for acetylcholine on 
the guinea pig's ileum, (Fig. 9 A). 
Activity was present in both the control and the challenge fluids, suggesting 
TABLE HI 
Deslruclion  , r Exogenous  Acetyl~holine*  by Isolated Atria~ 
Time  ACh remAinln~  in solution§  Initial ACh remaining in solution 
0 
1 
4 
6 
8 
12 
males X 10-4 
10.8 
10.8 
9.5 
9.1 
8.2 
7.1 
% 
100 
100 
88 
84 
76 
66 
* Acetylcholine  Chloride (Merck), ACh. 
4 atria (dry weight -- 98.5 nag) handled as single sample. 
§ Bioassay on the guinea pig ileum standardized with Aeetylcholine. 
that a  certain amount of spontaneously released material had accumulated in 
the eserinized medium. Challenge with toxin clearly increased the concentration 
of this material, since the addition of 0.6 ml of the challenge solution produced a 
contraction that was 2.5  times greater than that given by an equal volume of 
the control. In the presence of 7.5 X  10  ~5 ~  atropine, the response to both the 
test and control solutions was blocked, whereas the tissue was still responsive 
to histamine under these conditions. 
In a second release experiment, 12 atrial pairs were challenged with twice the 
concentration of toxin used earlier, but for half the time. The bioassay record 
(Fig. 9 B) permits the construction of a standardization curve to acetylcholine 
and thus the calculation of the concentrations (acetylcholine equivalents)  of 
the active atropine-sensitive material liberated. On this basis, it was computed 
that the control solution contained 9.8 X  10  -4 #moles of spontaneously released 
acetylcholine, and that the challenge solution contained 18.8 X  10  --4 #moles as 1414  ACTION OF  STR-EPTOLYSIN 0  ON  CARDIAC TISSUE 
acetylcholine equivalents. Thus, the net release due to the action of streptolysin 
O was 9.0 ×  10-4/~moles. Correcting this value by the dry weight of the tissue 
(247 mg), and for the reaction period (90 sec), the unit rate of release was 2.5 
X  10  -3 gmoles acetylcholine/g of dry atrium/min. 
The Effects of Streptolysin 0  on the Isolated Ventricle.--The characteristics  of 
the response of the isolated  atria to streptolysin 0  having been examined,  it 
A. 
ACh  CHALL 
1.0  0.1  0.6  0.6  1.0  1.0  1.0  1.0  0.1 
A  A  A  A 
B° 
[.:/ 
ACh  ACh 
1.5  0.1  0.15  0.2 
CON  CHALL  CHALL t  CHALL  |  ACh  t  H 
1.0  r.O  2.0  120111.5  0.1 
A  .A  A 
FIG. 9.  Biological identification of aeetylcholine release by streptolysin O-treated  atria. 
Bioassay on the guinea pig ileum of solutions bathing challenged atria (CHALL), and con- 
trol incubation solutions (CON); comparison with acetylcholine (ACh) standards.  Numbers 
represent milliliters of sample added to the bath (final volume, 3.5 ml). Acetylcholine standard, 
1 X  10-6 ,J; histamine (I-I) standard,  1 X  10-~ 5; atropine (A) added to a final concentra- 
tion of 7.5  X  10-  B ~. Trace A, 10 atria; trace B, 12 atria (see text). 
remained to demonstrate the effects of the toxin on the isolated  ventricular 
myocardium. 
As mentioned earlier, electrically driven ventricle strips, obtained from strep- 
tolysin-intoxicated hearts in ventricular arrest,  appeared  to function normally. 
Similarly,  the exposure  of ventricle  strips  obtained from normal,  untreated 
hearts to high concentrations of active toxin (up to 400 HU/ml)  established 
that streptolysin O had no detectable effect on the rate and amplitude of con- 
traction nor upon the configuration  of the intracellular potential (Fig.  10 A). B.  A.  REITZ,  D..]'.  PRAGER~ AND  G.  A.  ~FEIGEN 
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F~o. 10. Oscillographic  recordings  of the contractions  and intracellular  potentials  o~ an 
isolated ventricle strip preparation:  A. Before  challenge, 60 sec after challenge with strep- 
tolysin O, and 60 sec after challenge with acetylcholine. B. Before, 120 sec after,  and 10 vain 
after challenge with serotonin creatinine sulfate at 37°C. 1416  ACTION  OF  STREPTOLYSIN  0  ON  CARDIAC  TISSUE 
In addition, this preparation was completely insensitive to acetylcholine; con- 
centrations in excess of 1.4 X  10  -~ ~  failed to have any effect on the recorded 
parameters (Fig. 10 A). 
The Significance  of Acelylcholine  Release to the Cardiotoxidty  of Streptolysin 
O.--Having demonstrated that acetylchofine could be released from atria by 
streptolysin  0  and  that  the  liberation  of this  transmitter  substantially ac- 
counted for the functional changes observed in this tissue, we thought it ap- 
propriate  to consider the contribution of this phenomenon to the toxicity of 
Fro. 11.  A comparison between the actions of streptolysin  O and acetylcholine on the iso- 
lated heart at 37°C. Two concentrations  of toxin (B and D) are compared with their func- 
tionally equivalent  doses  of acetylcholine  (A and C). 
streptolysin O in the intact organ. Fig. 11 compares the effects of two concentra- 
tions of streptolysin O with their functionally equivalent doses of acetylcholine. 
There  is  a  striking similarity between  the  transient depression  of  rate  and 
amplitude resulting from acetylcholine administration and the initial phase of 
the toxin effect. The difference between the actions of the two agents lies in the 
recovery phase. The recovery of the acetylcholine-treated hearts was complete, 
whereas the toxin-treated organs recovered only partially, and then declined 
irreversibly. 
The  effects of atropine and eserine on the response of the whole heart to 
streptolysin O are demonstrated in Fig. 12. The initial rate of decrease of ampli- 
tude produced by 132 units of active toxin was accelerated in the presence of B. A. P.EITZ,  D. J. PRAGER, AND G. A. IrEIGEN  1417 
6.9 X  10  -7 ~  eserine, whereas atropine (1.4 X  10-  e ~) blocked this initial phase 
even when the streptolysin O dose was doubled. Although these agents greatly 
influenced the course of the response in its initial stages, they had no effect on 
the rate of the irreversible decline of the terminal phase as evidenced by the 
convergence of the three curves of Fig. 12 at about 4 mln. In addition, these 
agents had no measurable influence over the changes in perfusion flow rate pro- 
duced by challenge with the toxin. 
t) 
tU 
t~ 
nr 
IOO 
9C 
8c 
70 
60 
50 
4C 
2  I  I 
0  40  80 
I 
120  160  200  240 
TIME AFTER CH/~..LENGE(SE~ 
The Effects of Serotonin on Cardiac, Tissues of the Guinea Pig.--Since certain 
anti-serotonln agents were protective against the lethal toxicity of streptolysin 
O in rabbits and mice (5), we investigated the possible role of serotonin in the 
in vitro cardiotoxicity of streptolysin O. 
Very high concentrations of serotonin creatinlne sulfate (2.0  X  10  -4 M) ap- 
plied to the peffused heart produced a  slight, fully reversible decrease in rate 
and amplitude of contraction, accompanied by a marked increase in the per- 
fusion rate  (up to 100%). The serotonln-blocking agent, UML-491, modified 
this response but had no effect on any part of the response of the whole heart 
to 240 units of streptolysin O. 
FIo. 12. The initi~ phase  of the response  of the ~lAted hesrt to 132 HU of streptolysin  O 
(O  O). The effect  of this same dose when edm~n~tered  in the pre~mce of 6.9 X 10  -7 
eserine (A  A), and double  this dose  when given  in the presence of 1.4 X 10-* u atropine 
(B-----II). (37"C.) 1418  ACTION  OF  STREPTOLYSIN  O  ON  CARDIAC  TISSUE 
Electrically driven atria responded only to very high concentrations of either 
•  serotonin creatinine sulfate or n-acetyl serotonin. For example, a concentration 
of 4.7 X  10-  6 M of the n-acetyl derivative produced a rapid, 110%  increase in 
amplitude which continued until renewal of the medium. Even such high con- 
centrations failed to produce any measurable alterations in the intracellular 
potential. UML-491  (1.25  X  10  -3 mg/ml) protected the preparation against 
these serotonin doses but  did not alter its response to  240  HU/ml of strep- 
tolysin O. 
Similarly, large doses of these compounds increa~eA the amplitude of contrac- 
tion of the electrically driven ventricle strip, but had no effect on the configura- 
tion of the action potential. Fig.  10 B  shows the results of exposing such  a 
preparation to 1 X  10  -7 ~¢ serotonin for 120 sec and  10 min; the marked  po- 
tentiation  of  the  contraction  is  not  accompanied  by  observable  electrical 
ahanges. 
Evidence that the Cardiotoxic Factor is Streptolysin O.--Although the strepto- 
lysin O  preparations used were highly purified, they were known to be con- 
tamlnated with small amounts of one or two other antigens (4,  10).  Certain 
properties of streptolysin O were used to ensure that the effects considered in 
this report were owed to the action of that molecule (1, 2, 4) and not to possible 
impurities. 
Inactivity of the oxidized state: In tests on the whole heart and isolated atria, 
reversibly oxidized Group A and Group C toxins--having potential hemolytic 
potencies of up to 1200 HU/ml--produced none of the changes in rate and am- 
plitude of contraction which characterized the actions of the same concentration 
of the reduced material. Similarly, bubbling oxygen through active streptolysin 
O reduced the potency of the toxin to a degree dependent upon the extent of 
oxygenation. 
Inhibition  by cholesterol: Aliquots of the activated toxin were incubated with 
the cholesterol suspension and then tested on the isolated atria. Fig. 8 D shows 
that such a treatment completely inhibited the effects of 89 HU/ml of the toxin 
preparation. Incubation of atria with cholesterol suspension, followed by thor- 
ough washing, failed to protect  the tissues  from subsequent challenge with 
active streptolysin O. 
Heat inactivation: The thermolability of our toxin preparations was demon- 
strated by heating the toxin-buffer solutions (56°C for 10 rain) prior to activa- 
tion with cysteine. In the example of Fig. 8 E, heat-treated toxin produced no 
response when added to the bath (final concentration 115 HU/ml). 
Neutralization by specific antibody: Pooled normal human T-globulin at a con- 
centration of 160 mg/ml was used in these studies. An aliquot of 0.5  ml of 
Group C toxin, activated with cysteine and diluted to give a final concentration 
of 5880 HU/ml, was incubated at 24°C for 5 min with 0.25 ml of the human q,- 
globulin. The data in Table IV demonstrate that the severe depression of atrial B.  A.  REITZ, D.  J.  PRAGER~ AND  G. A.  ~'EIGEN  1419 
contraction produced by three doses of untreated  toxin was completely pre- 
vented by preincubating the toxin with antibody. Controls, in which strepto- 
lysin  0  was  similarly  incubated  with  human  sermn  albumin  or  bovine 3'- 
globulin before being tested on the atria, showed that these proteins provided 
no protection against the effects of the toxin. 
TABLE IV 
Neutralization by Antibody (11t5") of the Toxicity of Streptolysin 0  on the Isolated Atria 
Changes in 
Exp, No.  Atria No.  Strep. 0  Protein*  amplitude (AA) 
and rate (AR) 
I 
II 
III 
ltU/ml 
112 
112 
136 
136 
136 
184 
184 
184 
mgl~d 
2.36  IHG 
2.36 IHG 
1.34  IHG 
0.43  BGG 
1.34 IHG 
1.49 HSA 
% 
-64 AA 
--17 AR 
No change 
No change 
-57 A/k 
--5 AR 
No change 
-48 AA 
--0 AR 
--88 AA 
--77 AR 
No change 
--48 AA 
-- OAR 
* 1TIG, immune human globulin (Squibb). HSA, human serum albumin (Cutter). B GG, 
bovine gamma globulin (Armour). 
DISCUSSION 
These studies, performed with rather highly purified toxin preparations, con- 
firm the in vitro findings of Kellner et al. (2) who demonstrated the ability of 
microgram quantities of reduced streptolysin 0  to induce cardiac standstill in 
isolated mammalian hearts. In addition,  however, it has been shown that the 
response of the whole heart to this toxin consists of two separate and distinct 
phases. There is initially a rapid, but transient, decrease in the rate and ampli- 
tude of contraction associated with the release of acetylcholine from the atria. 
These  events  are  superimposed  on  the  second  phase,  a  gradual,  irreversible 
decline in ventricular contraction. 
The initial phase appears to be entirely atrial in origin and exactly parallels 
the action of the toxin on the isolated atria. Both the whole heart and the atria 
show an immediate, dose-dependent reduction in rate and amplitude of con- 1420  ACTION OF STP.JEPTOLYSIN O  ON CAIU)IAC TISSUE 
traction followed by spontaneous recovery. This is complete in the isolated atria, 
but in the whole organ it is interrupted by the gradual and irreversible  decline 
in ventricular function. The transient depression  can be accounted for by the 
toxin-induced release of acetylcholine since (a) there is excellent correspondence 
between the actions of streptolysin O and acetylcholine on the whole heart and 
on the isolated atria; (b) the increase in the rate of repolarization of the atrial 
action  potential  caused by streptolysin O  is  characteristic  of the  action  of 
acetylcholine; (c) atropine modified the initial phase of the reaction of the whole 
heart  to streptolysin O and  completely protected the isolated atria  from its 
effects; (d) eserine aggravated the transient depression  in the whole heart and 
isolated atria;  and, finally,  (e) acetylcholine was pharmacologically identified 
in the solutions bathing multiple atria challenged  with streptolysin O. 
The initial difficulties in recovering this acetylcholine can be understood after 
consideration of the kinetics of its release and destruction. Endogenous trans- 
mitter is released in dose proximity to the cholinergic  receptors so that small 
amounts produce rapid and profound changes. This action is necessarily tran- 
sient in nature, however, because of rapid enzymatic hydrolysis. Any acetyl- 
choline which escapes destruction encounters barriers to diffusion from its site 
of release  to the bulk phase medium, so that only a  small percentage can be 
recovered from the solution surrounding the tissue. 
These problems were overcome by using large quantities of tissue, high doses 
of toxin, and by blocking the enzymatic destruction of acetylcholine with eserine. 
We were thus able to detect, biologically,  a net release  of 2.5 X  10  -~ #moles 
acetylcholine/g of dry tissue/rain from atria challenged  with toxin. The rate of 
destruction of exogenous acetylcholine,  estimated from the data of Table HI, 
amounts to 3.4  X  10  -~ #moles acetylcholine/g of dry atrium/rain.  Although 
these quantities and rates are gross approximations of the actual acetylcholine 
release  and destruction at the cellular  level,  they provide evidence of the for- 
midable barriers to quantitative  recovery. 
The observed atrial tachyphylaxis to repeated doses of streptolysin O could 
have come about because of an interference with the tissue receptors for acetyl- 
choline, or because of a defect in the apparatus concerned with either the metab- 
olism or release  of the compound. Although  prellmiuary  experiments on  this 
question indicate that  there is no alteration in the tissue receptor for acetyl- 
choline,  these studies were not sufficiently  critical,  and we are not yet able to 
distinguish  with certainty among these possible defects. 
The terminal phase of streptolysin O toxicity in the whole heart is a gradual 
loss of force of contraction. This defect apparently does not result from damage 
to the myocardial contractile mechanism itself but to the system which distrib- 
utes the excitatory impulses. That the contractile mechanism is functional was 
established by the ability of isolated strips of myoeardium from arrested ven- 
tricles of insulted hearts to contract normally when artificially  stimulated. In B. A. REITZ, D. J. PRAGER, AND G. A. ~EIGEN  1421 
addition, high concentrations of streptolysin O had no toxic effects on isolated 
ventricle strips from normal hearts. This is in conformance with  the findings 
of Goullet et ah (21) who observed only a transient, positive inotropic effect in 
the  isolated ventricle  strip  of the rat.  The observation  that,  at ventricular 
standstill,  the  atria  beat  normally  indicates  that  the  sinoatrial  node  is 
functional. These findings  suggest that the ventricular arrest results not from 
damage to the contractile tissue of the ventricles, but to the atrioventricular 
node or to other components of the conduction system. This  conclusion  sub- 
stantiates  the in vivo  findings  of Halbert et al.  (4)  and  Halpern  et  al.  (3) 
whose electrocardiographic  data  showed conduction  defects and  ventricular 
automatism. 
It is evident that acetylcholine plays no part in the ventricular depression of 
the irreversible  terminal phase. The studies on the isolated intact heart demon- 
strated (a)  that atropine and eserine had no effects on the ultimate decline  of 
ventricular force of contraction, and (b) that hearts challenged  with large doses 
of acetylcholine recovered fully from cardiac arrest and failed to show any of 
the long term effects characteristic of the terminal phase produced by strepto- 
lysin O.  Additionally,  isolated ventricle  strips  from normal  hearts  show no 
electrophysiological  or mechanical changes subsequent to huge doses of strepto- 
lysin O  or  acetylcholine. This is in  conformance with  previous work which 
established the lack of parasympathetic innervation of the ventricles and their 
insensitivity to acetylcholine (22). 
The analysis of the cardiac response to larger doses of toxin is complicated by 
the immediate and permanent cessation of coronary perfusion. Fig. 2 (dashed 
line)  shows the decrease in  contraction  amplitude  resulting  from artificially 
blocking coronary perfusion. This was also shown by Kellner et al.  (2) who 
stopped coronary flow and noted a  rapid  decrease in ventricular  contractile 
force which,  however, recovered completely after restoration of normal perfu- 
sion.  Thus,  at high  levels of streptolysin O intoxication,  it is not possible to 
distinguish between the deleterious effects  of anoxia and the decreased ventricular 
activity owing to the action of the toxin on impulse conduction. Such a distinc- 
tion, however, is possible with lower amounts of toxin which invariably lead to 
an irreversible decrease in ventricular function, though they produce only tran- 
sient lowering  of perfusion. 
Contrary to the experience with intact animals (5), our work failed to pro- 
duce any  evidence that serotonin plays an active role in the in vitro cardio- 
toxicity of streptolysin O. On the contrary, the changes produced by the ex- 
tremely large doses of the amine,  i.e.,  (a) positive inotropic and chronotropic 
effect on atria,  (b) positive inotropic action on the driven ventricle strip, and 
(c) increased coronary flow in the whole heart, are opposite to the changes pro- 
duced by the toxin. Furthermore,  serotonin antagonists appeared to have no 
effect against the actions of streptolysin O in the isolated atria or whole heart. 1422  ACTION OF STREPTOLYSIN  0  ON CARDIAC TISSUE 
It is interesting to consider the results of these studies and those of Halbert 
et al.  (4)  in relation to certain of the clinical manifestations of streptococcal 
infections and their sequelae in man. The electrocardiograms  of patients suf- 
fering from scarlet fever, streptococcal  pharyngitis, and rheumatic fever often 
show abnormalities characteristic of damage to the atrioventricular node or 
ventricular conduction system. The most common change  is prolongation of 
the P-R interval, but partial atrioventricular heart block, atrioventricular dis- 
sociation, inversion of the T wave, and bundle branch block are also encountered 
(23, 24). These observations are of interest in light of Halhert's in vivo electro- 
cardiographic  findings of conduction defects following injection of streptolysin 
O into rabbits, and our own evidence that the in vitro toxicity of streptolysin O 
for the guinea pig heart results from damage to the conduction system. If the 
toxin is present during the course of rheumatic fever, as suggested by the high 
anti-streptolysin O  titers  in  patients  suffering  from  the  disease  (25), the 
present findings are in accord with the concept that this molecule may be re- 
sponsible for the conduction defects represented  by the diagnostic  abnormal- 
ities of the electrocardiogram. 
SIYM~RY 
The response of isolated guinea pig hearts to perfusion with purified strepto- 
lysin O is characterized by a rapid, but transient, decrease in rate and amplitude 
of contraction; these reactions  are superimposed upon a gradual, irreversible, 
loss of ventricular contractility. At ventricular standstill,  the atria continue to 
beat spontaneously in a normal way. Isolated ventricle strips prepared from such 
preparations can be driven electrically,  and their behavior is functionally in- 
distinguishable  from that of similar preparations made from normal hearts. 
Tests on spontaneously beating isolated atrial pairs show that the toxin in- 
duces  a  dose-dependent,  reversible,  decline  in  rate  and  amplitude which  is 
accompanied by a marked, but transient, increase in the velocity of repolariza- 
tion of the intracellular potential. The atrial reactions were completely blocked 
by atropine and potentiated by eserine. 
Acetylcholine was detected in the perfusates obtained by incubating a large 
pool of atrial tissue with active toxin, supporting the inference that the transient 
mechanical and electrophysiological reactions to toxin might be consequences of 
the release of acetylcholine from these tissues by the active toxin. 
Control studies showed that only the active toxin had the capacity to induce 
the cardiac  responses. The toxin was active only in the reduced  but not the 
oxidized form. The effects of the active toxin were modified if it were heated 
prior  to challenge,  and they could be neutralized by specific antiserum and 
inhibited by cholesterol. 
Since the driven ventricle strip was mechanically and electrophysiologically 
insensitive  to streptolysin O, the irreversible changes in the whole heart must 
have occurred because of a defect in the atrioventricular conduction system. B. A. I~EITZ, D. J. PRAGER, AND  G. A. ~EIGEN  1423 
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